Sol-Gel Technologies (SLGL) Competitors $23.96 -0.86 (-3.45%) Closing price 03:59 PM EasternExtended Trading$23.96 0.00 (0.00%) As of 04:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLGL vs. CHEK, DRCT, CAPR, GLUE, ALEC, OCGN, DRUG, SCPH, GALT, and TVRDShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Check-Cap (CHEK), Direct Digital (DRCT), Capricor Therapeutics (CAPR), Monte Rosa Therapeutics (GLUE), Alector (ALEC), Ocugen (OCGN), Bright Minds Biosciences (DRUG), scPharmaceuticals (SCPH), Galectin Therapeutics (GALT), and Tvardi Therapeutics (TVRD). Sol-Gel Technologies vs. Its Competitors Check-Cap Direct Digital Capricor Therapeutics Monte Rosa Therapeutics Alector Ocugen Bright Minds Biosciences scPharmaceuticals Galectin Therapeutics Tvardi Therapeutics Sol-Gel Technologies (NASDAQ:SLGL) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Is SLGL or CHEK more profitable? Check-Cap has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -14.25%. Check-Cap's return on equity of 0.00% beat Sol-Gel Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Sol-Gel Technologies-14.25% -11.80% -9.39% Check-Cap N/A N/A N/A Which has more volatility and risk, SLGL or CHEK? Sol-Gel Technologies has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Do insiders and institutionals believe in SLGL or CHEK? 26.2% of Sol-Gel Technologies shares are owned by institutional investors. Comparatively, 1.1% of Check-Cap shares are owned by institutional investors. 66.5% of Sol-Gel Technologies shares are owned by insiders. Comparatively, 0.5% of Check-Cap shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has better earnings and valuation, SLGL or CHEK? Sol-Gel Technologies has higher revenue and earnings than Check-Cap. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSol-Gel Technologies$11.54M5.79-$10.58M-$1.23-19.48Check-CapN/AN/A-$25.15M-$3.00-0.71 Does the media refer more to SLGL or CHEK? In the previous week, Check-Cap had 11 more articles in the media than Sol-Gel Technologies. MarketBeat recorded 15 mentions for Check-Cap and 4 mentions for Sol-Gel Technologies. Sol-Gel Technologies' average media sentiment score of 0.90 beat Check-Cap's score of 0.82 indicating that Sol-Gel Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sol-Gel Technologies 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Check-Cap 2 Very Positive mention(s) 1 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySol-Gel Technologies beats Check-Cap on 7 of the 12 factors compared between the two stocks. Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SLGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$66.83M$4.31B$5.75B$10.27BDividend YieldN/A1.27%5.72%4.60%P/E Ratio-19.4810.9175.1726.41Price / Sales5.7915.54455.9688.49Price / CashN/A7.5125.8129.91Price / Book2.313.2613.256.28Net Income-$10.58M-$134.23M$3.29B$270.38M7 Day Performance-13.05%-2.75%0.76%2.79%1 Month Performance55.15%4.47%4.63%6.00%1 Year Performance286.37%34.67%73.44%25.97% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies0.7498 of 5 stars$23.96-3.4%N/A+297.2%$66.83M$11.54M-19.4850News CoverageAnalyst UpgradeShort Interest ↑Gap DownCHEKCheck-Cap0.3824 of 5 stars$0.68+1.5%N/A-58.3%$3.92MN/A-0.2380News CoverageGap UpTrading HaltedDRCTDirect Digital2.9117 of 5 stars$0.43-2.3%$6.00+1,311.8%-83.3%$9.80M$62.29M-0.2360Negative NewsCAPRCapricor Therapeutics2.3629 of 5 stars$6.35-5.8%$22.56+255.2%+38.6%$308.13M$22.27M-3.87101GLUEMonte Rosa Therapeutics2.8679 of 5 stars$4.80-2.8%$15.33+219.4%-20.9%$305.09M$75.62M13.3390Trending NewsGap UpALECAlector3.9186 of 5 stars$2.76-8.3%$4.17+51.0%-54.4%$304.65M$100.56M-2.38270Positive NewsAnalyst UpgradeOCGNOcugen1.9904 of 5 stars$1.03flat$6.00+482.5%-11.6%$301.07M$4.05M-5.1580News CoveragePositive NewsGap UpDRUGBright Minds Biosciences3.282 of 5 stars$42.97+1.7%$81.00+88.5%+3,723.5%$297.54MN/A-46.20N/APositive NewsAnalyst ForecastSCPHscPharmaceuticals4.5136 of 5 stars$5.58+0.2%$7.78+39.5%+2.6%$296.87M$36.33M-3.0830Positive NewsShort Interest ↓GALTGalectin Therapeutics2.073 of 5 stars$4.67+1.5%$6.00+28.5%+87.1%$294.68MN/A-7.309News CoverageGap UpTVRDTvardi Therapeutics2.7208 of 5 stars$29.66-4.7%$64.25+116.6%N/A$291.73M$7.14M0.0080 Related Companies and Tools Related Companies Check-Cap Alternatives Direct Digital Alternatives Capricor Therapeutics Alternatives Monte Rosa Therapeutics Alternatives Alector Alternatives Ocugen Alternatives Bright Minds Biosciences Alternatives scPharmaceuticals Alternatives Galectin Therapeutics Alternatives Tvardi Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLGL) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLGL Stock Alerts